久久久精品欧美一区二区三区,国产欧美久久久精品影院,亚洲AV福利天堂一区二区三亚洲欧洲日韩国产AⅤ在线,亚洲成av人在线视,四虎国产精品永久地址99自拍三区一级国产片,亚洲男人的天堂久久无在线观看免费黄视频,亚洲一级特黄大片在线播放,国产成人精品区在线观看

Vaccine
Home > Application > Vaccine > Virus-like particle (VLP) vaccine

Virus-like particle (VLP) vaccine

Most currently available vaccines are mainly based on inactivated or attenuated live vaccines. Although these traditional vaccines have been used effectively against various infectious diseases, some of them have several limitations, including low likelihood of inducing a stronger immune response and their poor efficacy. Recent outbreaks of infectious diseases demonstrate the need to develop robust vaccines to overcome these limitations. The main challenge is to develop new technical approaches and boost immunity without compromising safety, efficacy and tolerability. Recent advances in vaccines based on DNA, mRNA, and recombinant viral vectors provide effective vaccine development methods for difficult-to-target pathogens and control infectious disease outbreaks.


Virus-like particle (VLP) technology provides an alternative platform for the development of effective vaccines against serious infectious diseases, and it is being developed in parallel with vaccines based on mRNA and viral vectors. VLPs are also much more immunogenic than other subunit vaccines because they present repetitive epitopes on their surface, making them more reliably detectable by the immune system. On the other hand, subunit vaccines may be less immunogenic due to misfolding of the target antigen or insufficient presentation to the immune system, and moreover, they require adjuvants and repeated vaccinations to elicit an adequate immune response. The term virus-like particle was first described by Fraenkel-Conrat and Williams (1955) by recombining tobacco mosaic virus (TMV) particles from purified RNA and protein components. The potential of these nanostructures to induce potent immune responses was then further investigated. The VLP platform can overcome various problems typically associated with traditional vaccines; specifically, infectivity, reversion to virulent forms, mutation risk associated with live attenuated vaccines, and reduced immunogenicity, toxicity instability, low yield and long formulation time associated with inactivated vaccines.


These bio-inspired nanostructures feature repetitive and high-density antigens from different viruses, helping to trigger a strong immune response. Furthermore, these highly immunogenic molecules possess the self-assembling properties of viral proteins. They are biocompatible and have the potential for structural flexibility during synthesis. They can be chemically or genetically modified and exhibit increased stability, uniformity, and functionality, and are considered effective tools in various biomedical applications. Depending on the presence or absence of a lipid membrane, VLPs can be classified as either enveloped or nonenveloped.


However, some of the key challenges associated with VLPs are low stability, difficult downstream processes, high production costs, and sensitivity to environmental conditions. Many different VLPs have been synthesized in various expression systems, such as bacteria, yeast, mammalian cells, insect cells, and plants. VLP-based vaccines have the potential to be used to treat various infectious diseases, including HIV, influenza, hepatitis B, hepatitis E, malaria, Ebola virus, SARS-CoV-2, Zika virus, dengue fever, and foot-and-mouth disease, among others. Several VLP-based vaccines have been licensed and marketed, including Engerix-B? and Recombivax HB? for HBV, Gardasil? and Cervarix? for HPV, Hecolin? for HEV, and Mosquirix? for malaria.

Related Products
Contact Us
  • Tel.: +86 021 6434 0155
  • E-Mail: marketing@duoningbio.com
  • Address: Building 30, No. 1525 Minqiang Road, Songjiang District, Shanghai
Message

Copyright ? Shanghai Duoning Biotechnology Co., Ltd. All Rights Reserved Sitemap | Technical Support: Reanod

WeChat
WeChat

Message-

Duoning Biotechnology

+86 021 6434 0155

成人精品一区二区激情| 国产欧美精品一区二区三区四区| 久久久久国色AV免费观看| 欧美最新三级手机在线| 亚洲国产成人VA在线观看| 久久精品国产精品亚洲下载| 亚洲AV永久纯肉无码精品动漫| 日本xxxx高清色视频在线播放| 学生妹国产在线第一页| 免费网站看V片在线18禁无码| 精品久久久无码人妻字幂| 一区二区视频日韩免费| 自拍三区一级国产片| 中文乱码人妻系列一区二区| 欧美精品中文字幕亚洲专区| AV狼友无码国产在线观看不卡| 久久99国产精品久久99| 一区二区日韩国产精品| 日本精品精品一二区一本到| 在线免费视频人妻| 久久不见久久见免费影院www日本| 亚洲一久久久久久久久| 中国女人内射6XXXXX| 精品久久久久久中文墓无码| 精品国产高清久久久久久| 亚洲中文字幕一区精品自拍,秋霞鲁丝无码| 亚洲一区二区不三区不卡| 吃下面吃胸在线看无码| 国产亚洲人成网站在线观看| 自拍三区一级国产片| 波多野结衣乳巨码无在线观看| 欧美巨大XXXX做受l色诱久久av| 无码人妻精品一区二区蜜桃网站| 色综合久久久无码中文字幕| 免费A级毛片无码A∨免费软件| 日韩一区二区三区免费观看女同| 野花视频在线观看免费观看最新| 九月婷婷人人澡人人添人人爽| 久久久国产99久久国产一| 精品一卡2卡三卡4卡乱码精品视频| 国产精品一区二区太大了|